ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma

Chiyu Zhang1, Honglin Hu1, Ruizhen Huang1

  • 1Department of Urology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

Frontiers in Surgery
|November 7, 2022
PubMed
Abstract

Related Concept Videos